NWPF

News ArchivesRead News

Clinical trial participation might help discover a cure for Parkinson’s

Wednesday May 23, 2012

Foxnews.com - Clinical trials are central to Parkinson's disease (PD) treatment breakthroughs and, ultimately, a cure. Unfortunately, 30 percent of clinical trials fail to recruit a single volunteer. Recruitment difficulties plague the vast majority of trials, resulting in greater expenses and delayed action, but by participating in a clinical study, you can be part of the solution.

Observational and interventional trials

There are two main kinds of clinical studies: interventional and observational. Interventional studies assess a treatment's effectiveness and safety. Observational studies, on the other hand, monitor the health of volunteers over an extended period, resulting in a deeper comprehension of PD.

Trials can bring a better understanding of treatment and prevention, genetics, detection and how to improve one's lifestyle with PD. Fewer than 10 percent of people with PD participate in these trials, a statistic which prompted actor and PD-advocate Michael J. Fox to suggest, "You may be the answer you're looking for."

Parkinson's Progression Markers Initiative (PPMI)

PPMI is a landmark research project expediting the advancement of medical research. Since there is currently no method for diagnosing PD before symptoms appear, scientists are working to uncover a biomarker.

By the time Fox noticed that his pinky was twitching one morning (a simple symptom of Parkinson's), 80 percent of his dopamine-producing cells were already gone. Lack of dopamine causes motor skills to deteriorate. If doctors had a cholesterol-type test for PD to identify at-risk people, they would have the ability to start treating patients before the disease progresses too far.

Most clinical trials seek to hone existent treatments. The ultimate goal of PPMI is to aid in finding a cure. Fox has described PPMI as "the most exciting piece of research out there."

CoQ10

Researchers have taken great strides in other studies. Neuroscientists at the University of California-San Diego launched a clinical trial of Coenzyme Q10 intervention in early-stage PD sufferers. This natural intervention appeared to counter the acceleration of PD.

Kira Schmid, a doctor of naturopathic medicine and director of Scientific Affairs for Life Extension, explained, "In this multicenter controlled study, 80 patients with early PD, not requiring treatment, were randomly assigned to a placebo or to CoQ10 at dosages of 300, 600, or 1,200 mg per day for 16 months or until disability required drug treatment."

Placebo patients indicated worsening PD than those with CoQ10. Conversely, the high-dose patients exhibited a lesser deterioration of motor skill function overtime.
Further trials are needed, however, to corroborate these results.

Get started

Scientists have identified more than 10 different genes and several environmental factors that might affect one's risk of developing PD. Therefore, neurologist and Ohio State professor Sandra Kostyk said, "We can not necessarily lump all Parkinson's patients together in trials and expect the same response in everyone."

To make advancements in PD research, experts suggest that a wide array of people participate in clinical studies, ranging from people with PD (at all stages) to people without PD.

Although financial donations for medical research are critical to success, active involvement is crucial too. You can search for clinical trials that are appropriate for you at Fox Trial Finder, PD Trials or NIH Exploratory Trials in Parkinson's Disease.

http://www.foxnews.com/health/2012/05/22/clinical-trial-participation-might-help-discover-cure-for-parkinsons/

Recent News

Jul 20 - Parkinson’s DREAM Challenge Uses Mobile Sensor Data to Monitor Health Based on Movement
Jul 19 - What Young-onset Parkinson’s Can Look Like
Jul 7 - Parkinson’s Patients Have a Higher Risk of Developing Melanoma — and Vice Versa, Study Finds
Jun 27 - The rogue protein behind Parkinson’s disease may also protect your gut
Jun 26 - Do Statins Increase Risk of Parkinson’s Disease? Some Researchers Think So
Jun 22 - A Confused Immune System Could Be Behind Parkinson's Disease
Jun 21 - Predicting cognitive deficits in people with Parkinson’s disease
Jun 20 - Gym offers classes in noncontact boxing for Parkinson’s patients
Jun 19 - Human Limitations Could Prevent Us From Advancing in Science. AI Could Help.
Jun 13 - Brain Cell Transplants Are Being Tested Once Again For Parkinson's
Jun 12 - Smell Test May Sniff Out Oncoming Parkinson's and Alzheimer's
Jun 8 - Smartphones Track Motor Function in Parkinson's Disease
Jun 8 - GKC Enrolls First Patient in Personal KinetiGraph Trial as Part of NPF’s Parkinson’s Outcomes Project
Jun 8 - Low-fat dairy intake may raise Parkinson's risk
Jun 6 - Patient Voices: Parkinson's Disease
Jun 1 - World-First Trials Have Been Launched to Treat Parkinson's And Blindness With Embryonic Stem Cells
Jun 1 - LIFE Shared This Remarkable Parkinson's Disease Story in 1959.
May 24 - Survival Rates Differ Widely in Parkinson's, MSA, Lewy Bodies
May 22 - Discovery may offer hope to Parkinson's disease patients
May 15 - Study offers answers on life expectancy for people with Parkinson's disease, Lewy body dementia